MA SONGJIANG (President) sold 0.0% of their position (174.00 shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/25/2025ACC: 0001140361-25-010234
DirectorOfficer· President
Since Oct 2023
-174.00
Net shares
Net seller
$1.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
174.00 disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−174.00
Price / share
$10.00
Trade value
$1.74K
% of position
0.0%
3/21/2025
2.83M→2.82M
Total
Net shares
−174.00
Net value
-$1.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/21/2025 | S · Sale | −174.00 | $10.00 | $1.74K | 0.0% | 2.83M | 2.82M |
| Total | −174.00 | -$1.74K | ||||||
Derivative Transactions0
No derivative transactions reported